Clinical trial
A Multi-Centre, Open-Label, Randomised Study to Assess the Efficacy, Durability and Safety of Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy (FLASH)
NCT00126308 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Centre, Open-Label, Randomised Study to Assess the Efficacy, Durability and Safety of Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy (FLASH)
- Lead sponsor
- Kirby Institute
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 30, 2005
- Completion date
- May 31, 2007
- Enrollment
- 100 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, hiv-associated lipodystrophy